New Key Statistics Module, Z-Score and F-Score
NAS:ARTV Key Ratios
Market Cap $ M | 266.43 |
Enterprise Value $ M | 240.86 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 376.83 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -5.18 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -7.85 |
EV-to-EBITDA | -8.17 |
PEG | -- |
Shares Outstanding M | 24.29 |
Net Margin (%) | -11,354.58 |
Operating Margin % | -12,223.90 |
Pre-tax Margin (%) | -11,354.58 |
Quick Ratio | 4.59 |
Current Ratio | 4.59 |
ROA % (ttm) | -31.53 |
ROE % (ttm) | -- |
ROIC % (ttm) | -106.09 |
Dividend Yield % | -- |
Altman Z-Score | -4.67 |
ARTV Number of Guru Trades
ARTV Volume of Guru Trades
Gurus Latest Trades with NAS:ARTV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ARTV is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Artiva Biotherapeutics Inc Insider Transactions
No Available Data
News about NAS:ARTV
Total 0- 1